RT Journal Article SR Electronic T1 The Causal Effect of Air Pollution on COVID-19 Transmission: Evidence from China JF medRxiv FD Cold Spring Harbor Laboratory Press SP 2020.10.19.20215236 DO 10.1101/2020.10.19.20215236 A1 Guojun He A1 Yuhang Pan A1 Takanao Tanaka YR 2020 UL http://medrxiv.org/content/early/2020/10/21/2020.10.19.20215236.abstract AB There is increasing concern that ambient air pollution could exacerbate COVID-19 transmission. However, estimating the relationship is challenging because it requires one to account for epidemiological characteristics, to isolate the impact of air pollution from potential confounders, and to capture the dynamic impact. We propose a new econometric framework to address these challenges: we rely on the epidemiological Susceptible-Infectious-Recovered-Deceased (SIRD) model to construct the outcome of interest, the Instrument Variable (IV) model to estimate the causal relationship, and the Flexible-Distributed-Lag (FDL) model to understand the dynamics. Using data covering all prefectural Chinese cities, we find that a 10-point (14.3%) increase in the Air Quality Index would lead to a 2.80 percentage point increase in the daily COVID-19 growth rate with 2 to 13 days of delay (0.14 ∼ 0.22 increase in the reproduction number: R0). These results imply that improving air quality can be a powerful tool to contain the spread of COVID-19.Competing Interest StatementThe authors have declared no competing interest.Clinical TrialNo clinical trials are conducted.Funding StatementN/AAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:No IRB is required.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe data will be made available upon the publication of the paper.